What happens when one of the most exciting stem cell biotechs ViaCyte teams up with a firm like CRISPR Therapeutics to use a combination of gene editing and cell therapy? Hopefully a synergistic partnership emerges that in this case can develop an effective stem cell-based therapy for diabetes. You can see a press release on …
ViaCyte & CRISPR Therapeutics team up to battle diabetes Read More »
Who decides whether a stem cell therapy is “good” or “bad”, and should that kind of a judgment be more focused on direct patient perspectives such as their stem cell therapy reviews as consumers or based on biomedical science? Both? I’ve written before about how stem cell patients are increasingly thinking of themselves as consumers …
Stem cell therapy reviews: knees, lung, autism, & Regenexx Read More »
Our California stem cell agency, CIRM, started as a baby even before I came to California in 2006 to start my lab here at UC Davis School of Medicine, but now CIRM or to use its full name the California Institute for Regenerative Medicine is I’d say a full-grown, mature adult at about age 13 …
Poll on refunding CIRM on eve of informational legislative hearing Read More »
Attorney Richard Jaffe, who has been an advocate for clinics to have the right to sell and patient to buy unproven therapies such as the stem cells sold by clinics and unproven cancer therapies, just did a kind of shocking u-turn on a specific point. Jaffe and I have very different philosophical views of the …
Attorney Jaffe, fan of less oversight, still clobbers Florida stem cell clinic firm Read More »
It’s a funny thing how having this blog can provide insights into unexpected stem cell events and news going on around the world such as, most recently, action by the government of Romania on stem cell firms there for alleged “dirty practices”, news that as far as I know has only been reported in Romanian. …
Romania fines 5 stem cell groups for alleged ‘dirty practices’ Read More »
I’m doing a Facebook Live question and answer on stem cells today, Monday, July 23 at Noon USA Pacific Time. Hopefully we’ll cover the exciting, legit research as well as the challenges in the field these days such as for-profit, unproven stem cell clinics out there, as well as everything in between. One possible good …
Ask Your Questions on Knoepfler Facebook Live on Stem Cells Today at Noon Read More »
If it seems to you like dramatic cautionary tales about CRISPR accompanied by all sorts of media are coming at us more frequently, it’s not your imagination. In the latest yesterday, it was reported in a new paper led by Allan Bradley that CRISPR-Cas9 results in sometimes large-scale chromosomal lesions at or even away from the …
Mulling over latest CRISPR tumult, this one from Nat Biot pub on DNA lesions Read More »
Over the weekends I try to catch up on more diverse reading and sometimes come up with a list of stuff I want to get to during this time, but I also put together weekend reads usually on Fridays as a kind of TGIF on The Niche for the wider audience here. So here’s the …
TGIF weekend reads: senolytics, new CRISPR, stem cells, & 3 wacky things Read More »
Periodically I also try to post (as I am today) specifically about stem cell good news amongst all the swirling developments out there. You can see the most recent past installment focused on good news here that include vascularized organoids. I recently stumbled on this quote that for me linked up the potential of stem cells …
What is the SCOTS Trial and why are some of its participants raising concerns? There’s a lot going on in Florida with non-FDA approved stem cell offerings. Even just related to stem cells for vision problems alone. While US Stem Cell has drawn the most attention related to patient allegations of severe vision loss in Florida …
15 still unanswered interview questions for stem cells for vision SCOTS trial docs Read More »